Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Global Development, Inc.
The study will develop and administer a discrete-choice experiment (DCE) to quantify tradeoff preferences of participants with mHSPC and locally-advanced prostate cancer in various countries. Data/surveys are being collected in: United States, Canada, UK, France, Spain, Japan, China and South Korea.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
For interviews (attribute prioritization and pretest interviews)
Diagnosis of mHSPC with or without previous experience with ADT
Able to read and understand the survey language
Able to provide informed consent For online survey
Diagnosis of mHSPC or locally-advanced prostate cancer with or without previous experience with ADT
